Literature DB >> 8863438

Reassessment of the phylogenetic position of the bacterium associated with Whipple's disease and determination of the 16S-23S ribosomal intergenic spacer sequence.

M Maiwald1, H J Ditton, A von Herbay, F A Rainey, E Stackebrandt.   

Abstract

Whipple's disease is a rare chronic illness associated with an unculturable bacterium that is constantly present in affected tissues. This bacterium was previously characterized at the molecular level by PCR and sequencing of the 16S rRNA gene. On the basis of 1,321 nucleotides of the sequence of its gene coding for 16S rRNA (16S rDNA), a phylogenetic relationship to the actinomycetes was established. In this study, we determined an almost complete 16S rDNA sequence (1,495 nucleotides), the 16S-23S ribosomal intergenic spacer sequence, and 200 nucleotides of the 23S rRNA gene. The 16S rDNA sequence was compared with the large number of actinomycete sequences that have been added to the database since the original study. Phylogenetic analysis revealed a branching position as the deepest branch of the cluster comprising the actinomycetes with group B peptidoglycan between this group and the family Cellulomonadaceae. This provides additional information on the phylogenetic position of this bacterium and some clues as to its characteristics. The spacer region between the 16S and 23S rRNA genes is 294 nucleotides long and does not contain tRNA genes. As has been shown in other instances, the increased variability of the ribosomal intergenic spacer compared with the 16S rRNA gene makes it a potential target for use in the differentiation of strains of the bacterium associated with Whipple's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863438     DOI: 10.1099/00207713-46-4-1078

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  20 in total

1.  Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of "Tropheryma whippelii" and its use for detection of "T. whippelii" in clinical specimens by PCR.

Authors:  S Morgenegg; F Dutly; M Altwegg
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Evaluation of a specific nested PCR targeting domain III of the 23S rRNA gene of "Tropheryma whippelii" and proposal of a classification system for its molecular variants.

Authors:  H P Hinrikson; F Dutly; M Altwegg
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 4.  Whipple's disease.

Authors:  Florence Fenollar; Didier Raoult
Journal:  Curr Gastroenterol Rep       Date:  2003-10

5.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

6.  Rare but not so rare: The evolving spectrum of Whipple's disease.

Authors:  J M Conly; B L Johnston
Journal:  Can J Infect Dis       Date:  2001-05

7.  Whipple's disease-generalized stage.

Authors:  Peter Jackuliak; Tomas Koller; Lahim Baqi; Lukas Plank; Zora Lasabova; Gabriel Minarik; Juraj Payer
Journal:  Dig Dis Sci       Date:  2008-06-04       Impact factor: 3.199

Review 8.  Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum.

Authors:  Marco Ventura; Carlos Canchaya; Andreas Tauch; Govind Chandra; Gerald F Fitzgerald; Keith F Chater; Douwe van Sinderen
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

9.  Global transcriptome analysis of Tropheryma whipplei in response to temperature stresses.

Authors:  Nicolas Crapoulet; Pascal Barbry; Didier Raoult; Patricia Renesto
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

10.  Tropheryma whipplei in children with gastroenteritis.

Authors:  Didier Raoult; Florence Fenollar; Jean Marc Rolain; Philippe Minodier; Emmanuelle Bosdure; Wenjun Li; Jean Marc Garnier; Herve Richet
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.